Skip to content
KYNT-AM
    • Homepage
Altruist Biologics’ Hangzhou Antibody-Drug Conjugate Facility Receives Provincial Regulatory Approval for Segmented Production

Author: ALTRUIST BIOLOGICS

Posted Date:

July 8, 2026
  • Altruist Biologics’ Hangzhou Antibody-Drug Conjugate Facility Receives Provincial Regulatory Approval for Segmented Production

    ALTRUIST BIOLOGICS
    July 8, 2026
  • Altruist Biologics’ Hangzhou Facility Secures First Commercial Manufacturing License

    ALTRUIST BIOLOGICS
    April 8, 2026
  • Altruist Biologics Launches Altru-CON™ High-Concentration Formulation Platform to Accelerate Biologics Development

    ALTRUIST BIOLOGICS
    March 4, 2026